Your point on the volume traded on the cse vs otc generally being much higher on the otc but not with this stock is interesting.
That means the company is relatively undiscovered by american investors right? If that's the case it's a good thing for us early birds getting these cheap worms.
A long way away from acredited investor money? I strongly disagree. I think they are one good potential deal with a good mj company to get financial backing. They have 45 deals under review last i heard and a conference at the beginning of next month that should give them opportunity to find more potential business investments. Also after listening to the CEO Harry Barr interview with 420i I get the impression he's the kind of guy who rubs shoulders with accredited investors on a daily basis.
Market Data 
Markets 
AI
